Description
MammoWave is a microwave imaging device for breast lesion detection, employing two antennas that rotate azimuthally (horizontally) around the breast. The antennas operate in the 1-9 GHz band and are set in free space, i.e., pivotally, no matching liquid is required. Microwave images, subsequently obtained through the application of the Huygens Principle, are intensity maps, representing the homogeneity of the dielectric properties of the breast tissues under test. In this paper, MammoWave has been used to realize tissue dielectric differences and localize lesions, after segmenting microwave images adaptively, by applying pulse coupled neural network (PCNN). The proposed method has been tested on microwave images of 61 breasts, verifying that the automated breast lesion localization in microwave imaging matches with the radiological localization. Subsequently, a non-parametric thresholding technique has been modelled to differentiate between breasts with no radiological finding (NF) and breasts with radiological findings (WF), i.e., with lesions that may be benign or malignant.
Date made available | 5 Oct 2021 |
---|---|
Geographical coverage | Perugia, Italy |
Keywords for datasets
- Keyword
- Microwave image processing
- Breast lesion localisation
- Neural network
Data Collection Method
- Description
- "The inclusion criteria allowed female volunteers above 18 years old with intact breast skin and with a radiologist study output obtained through conventional exams (mammography and/or ultrasound and/or magnetic resonance imaging) within the last month.
- All protocols and procedures were in accordance with both institutional and national ethical standards in research, and with World Medical Association Declaration of Helsinki (1964) and its later amendments or analogous ethical standards.
- Prior to the trial, all participants have been requested to read and sign both the informative sheet and informed consent form. Once a subject agrees to participate, she is assisted by the clinical study coordinator; the subject (prone) positions her breast in the cup, which is appropriately integrated in a bed. Specifically, three cups having varying sizes are available, and the clinical study coordinator chose the one that better fits the subject’s breast. Cups are made of polylactic acid (PLA), which has proven to be biocompatible. The thickness of the cup is 1 mm; it has been shown that such thickness does not impact microwave imaging. It is worthwhile pointing out that no matching liquid is used in the apparatus, and no breast compression has to be applied during acquisition. Microwave images have been first obtained in a cylindrical grid having radius equal to 7 cm (which corresponds to the radius of the receiving antenna), a radial sampling of 1 mm and an azimuthal sampling of 3°.
- Next, all images have been interpolated on a 2D Cartesian grid having X and Y sampling of 1 mm. We present here the results obtained using a set of data constituted of 61 breasts."
Data preparation and processing activities
- Description
- All data have been anonymized with only the staff who took the data aware of patients details. Specifically, information that identifies an individual patient has been removed and replaced by a 2-digit ID number code.
Statement on legal, ethical, and access issues:
- Description
- In-vivo validation of the MammoWave on volunteers in Perugia Hospital and Foligno Hospital was approved in 2015 by the Ethical Committee of Umbria, Italy (N. 6845/15/AV/DM of 14/10/2015, N. 10352/17/NCAV of 16/03/2017, N 13203/18/NCAV of 17/04/2018). The protocol concerns a feasibility study for detection of breast lesion using the proposed microwave mammogram apparatus, with the aim of quantifying the potential of the proposed microwave mammogram apparatus to be used for medical technology screening.
- The inclusion criteria allowed female volunteers above 18 years old with intact breast skin and with a radiologist study output obtained through conventional exams (mammography and/or ultrasound and/or magnetic resonance imaging) within the last month. All protocols and procedures were in accordance with both institutional and national ethical standards in research, and with World Medical Association Declaration of Helsinki (1964) and its later amendments or analogous ethical standards. Prior to the trial, all participants have been requested to read and sign both the informative sheet and informed consent form.